472 related articles for article (PubMed ID: 28704099)
21. DEATH RELATED TO PULMONARY METASTASIS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
Leite AK; Kulcsar MA; de Godoi Cavalheiro B; de Mello ES; Alves VA; Cernea CR; Matos LL
Endocr Pract; 2017 Jan; 23(1):72-78. PubMed ID: 27749128
[TBL] [Abstract][Full Text] [Related]
22. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
[TBL] [Abstract][Full Text] [Related]
23. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
Qiu ZL; Shen CT; Luo QY
Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
Matsuzu K; Sugino K; Masudo K; Mori K; Ono R; Yamazaki H; Masaki C; Akaishi J; Kiyomi Yamada H; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2020 Aug; 67(8):869-876. PubMed ID: 32350192
[TBL] [Abstract][Full Text] [Related]
25. Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy.
Ito Y; Miyauchi A; Ito M; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Kobayashi K; Kihara M; Miya A
Endocr J; 2014; 61(8):821-4. PubMed ID: 24871888
[TBL] [Abstract][Full Text] [Related]
26. Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators.
Qiu ZL; Shen CT; Sun ZK; Song HJ; Zhang GQ; Luo QY
Front Endocrinol (Lausanne); 2019; 10():903. PubMed ID: 31998236
[No Abstract] [Full Text] [Related]
27. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract][Full Text] [Related]
28. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
29. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
30. Be Aware of the Patient With Benign Follicular Thyroid Lesion Histology and Rising Thyroglobulin Level.
Slutzky-Shraga I; Sternov Y; Robenshtock E; Tzvetov G; Benbassat C; Hirsch D
Endocr Pract; 2018 Aug; 24(8):740-745. PubMed ID: 30106632
[TBL] [Abstract][Full Text] [Related]
31. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
32. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.
Nixon IJ; Whitcher MM; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Thyroid; 2012 Sep; 22(9):884-9. PubMed ID: 22827579
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.
Albano D; Panarotto MB; Durmo R; Rodella C; Bertagna F; Giubbini R
Endocrine; 2019 Jan; 63(1):79-86. PubMed ID: 30112608
[TBL] [Abstract][Full Text] [Related]
34. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
[TBL] [Abstract][Full Text] [Related]
35. Efficacy analysis of (131)I therapy and predictive value of preablation stimulated thyroglobulin for lung metastases from differentiated thyroid cancer.
Wu S; Wang H
Ann Endocrinol (Paris); 2013 Feb; 74(1):40-4. PubMed ID: 23337017
[TBL] [Abstract][Full Text] [Related]
36. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades.
Goffredo P; Sosa JA; Roman SA
World J Surg; 2013 Jul; 37(7):1599-605. PubMed ID: 23525600
[TBL] [Abstract][Full Text] [Related]
37. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score-matched analysis.
Guo H; Zhang N; Hu Y; Zhang F; Huang T; Shen N
Front Endocrinol (Lausanne); 2023; 14():1158581. PubMed ID: 37664843
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
[TBL] [Abstract][Full Text] [Related]
40. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
